eXoZymes Inc.
Organization details
- Legal name
- eXoZymes Inc.
- Former names
- Invizyne Technologies Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Nevada
- Headquarters city
- Monrovia
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- EXOZ
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0002010788
- EIN
- 83-4550057
Board of directors
- Since 2024
-
Christopher A. Marlett · DirectorSince 2024
-
Edgardo Javier Rayo · DirectorSince 2025
-
James Joseph Lalonde · DirectorSince 2024
-
James Ulrich Bowie · DirectorSince 2024
-
Lon E. Bell · DirectorSince 2024
-
Mohammad Hayat · Director · President & Chairman of BoardSince 2024
Director election results
Annual meeting of July 25, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
99.5%
-
99.5%
-
99.5%
-
100.0%
-
100.0%
-
100.0%
Board connections
3 of this board's directors also sit on 5 other boards. 1 is in the same sector.
- via Anthony Digiandomenico, Christopher A. Marlett and Mohammad Hayat
- via Mohammad Hayat
- via Anthony Digiandomenico
-
ENDRA Life Sciences Inc. Same sectorvia Anthony Digiandomenico
- via Anthony Digiandomenico
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $6,405
- 5 purchases by 1 insider
- Sold, last 12 months
- $34,854
- 3 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 12, 2026 | Perriman Damien Alan Officer (Chief Commercial Officer) | Open-market sale | −3,729 | $5.21 | $19,427 |
| Oct 9, 2026 | Perriman Damien Alan Officer (Chief Commercial Officer) | Option exercise | +3,922 | — | — |
| Aug 26, 2026 | Heltzen Michael Officer (Chief Executive Officer) | Open-market purchase | +4 | $7.58 | $30 |
| Aug 26, 2026 | Heltzen Michael Officer (Chief Executive Officer) | Open-market purchase | +251 | $7.35 | $1,845 |
| Aug 26, 2026 | Heltzen Michael Officer (Chief Executive Officer) | Open-market purchase | +250 | $7.60 | $1,900 |
| Aug 25, 2026 | Heltzen Michael Officer (Chief Executive Officer) | Open-market purchase | +250 | $7.52 | $1,880 |
| Aug 25, 2026 | Heltzen Michael Officer (Chief Executive Officer) | Open-market purchase | +100 | $7.50 | $750 |
| Aug 19, 2026 | Korman Tyler Paz Officer (Chief Scientific Officer) | Option exercise | +32,964 | — | — |
| Aug 19, 2026 | Perriman Damien Alan Officer (Chief Commercial Officer) | Option exercise | +19,612 | — | — |
| Aug 19, 2026 | Heltzen Michael Officer (Chief Executive Officer) | Grant or award | +8,841 | $6.40 | $56,582 |
| Apr 9, 2026 | Korman Tyler Paz Officer (Chief Scientific Officer) | Open-market sale | −750 | $10.53 | $7,898 |
| Apr 8, 2026 | Korman Tyler Paz Officer (Chief Scientific Officer) | Open-market sale | −750 | $10.04 | $7,530 |
| Apr 1, 2026 | Perriman Damien Alan Officer (Chief Commercial Officer) | Grant or award | +62,759 | — | — |
| Apr 1, 2026 | Perriman Damien Alan Officer (Chief Commercial Officer) | Grant or award | +8,887 | $8.44 | $75,006 |
| Apr 1, 2026 | Opgenorth Paul Hideo Officer (Vice President, Development) | Grant or award | +3,999 | $8.44 | $33,752 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about eXoZymes Inc.
How many directors are on eXoZymes Inc.'s board?
eXoZymes Inc.'s board has 7 directors: Anthony Digiandomenico, Christopher A. Marlett, Edgardo Javier Rayo, James Joseph Lalonde, James Ulrich Bowie, Lon E. Bell and Mohammad Hayat.
Are eXoZymes Inc. insiders buying or selling shares?
Over the last 12 months, eXoZymes Inc. insiders bought $6,405 of shares in 5 purchases and sold $34,854 of shares in 3 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="exozymes-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.